NUTX Share Price Performance
US$148.70
56.30 (60.93%)
36.9% undervalued intrinsic discount
US$235.50
Fair Value
Price US$148.70
AnalystConsensusTarget US$235.50
mstock US$165.64
AnalystLowTarget US$175.00
Fair ValueUS$235.50
Share Pricen/a
Nutex Health Inc. Stock Price
- 4 Narratives written by author
- 0 Comments on narratives written by author
- 46 Fair Values set on narratives written by author
NUTX Community Narratives
AN
Fair Value
·Fair Value US$235.5 36.9% undervalued intrinsic discount
Expanding Micro Hospitals Will Serve Growing Demand Amid Regulatory Risks
0users have liked this narrative
0users have commented on this narrative
16users have followed this narrative
MS
Fair Value
·Fair Value US$165.64 10.2% undervalued intrinsic discount
Nutex (NUTX) is undervalued
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AN
Fair Value
·Fair Value US$175 15.0% undervalued intrinsic discount
No Surprises Act Risks Will Shrink Margins Yet Foster Adaptation
0users have liked this narrative
0users have commented on this narrative
5users have followed this narrative
Expanding Micro Hospitals Will Serve Growing Demand Amid Regulatory Risks
Nutex Health is betting that small, convenient hospitals and stand-alone emergency rooms will win more patients as care keeps moving closer to where people live. But a big chunk of its business depends on winning payment disputes with insurers, and rule changes or slower collections could quickly squeeze cash and growth.Read more
AN
US$235.5
36.9% undervalued intrinsic discount
Fair Value
Revenue
4.89% p.a.
Profit Margin
27.28%
Future PE
6.29x
Price in 2029
US$274.63
No Surprises Act Risks Will Shrink Margins Yet Foster Adaptation
Key Takeaways Heavy reliance on out-of-network billing and arbitration exposes revenue to regulatory risks, payment delays, and shifting healthcare laws. Expansion into underserved markets and digital adoption support growth, but rising costs, competition, and evolving patient preferences threaten profitability and operational stability.Read more
AN
US$175
15.0% undervalued intrinsic discount
Fair Value
Revenue
5.25% p.a.
Profit Margin
21.15%
Future PE
7.95x
Price in 2029
US$204.51
Micro-hospitals Will Expand Outpatient Care Amid Tech And Regulatory Risks
Key Takeaways Accelerated revenue growth, margin expansion potential, and tech-driven efficiency position Nutex for outperformance amid industry shifts and upcoming regulatory changes. Strong patient satisfaction, local market gains, and capital strength support faster expansion, strategic acquisitions, and long-term earnings growth.Read more
AN
US$300
50.4% undervalued intrinsic discount
Fair Value
Revenue
25.55% p.a.
Profit Margin
0.81%
Future PE
182.99x
Price in 2028
US$307.9
Trending Discussion
No trending discussion available.
Recently Updated Narratives
MS
Nutex (NUTX) is undervalued
Fair Value: US$165.64 10.2% undervalued intrinsic discount
1 fair value setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
NUTX: Low EV EBITDA Multiple And Buyback Activity Will Support Future Upside
Fair Value: US$235.5 36.9% undervalued intrinsic discount
16 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
NUTX: Share Repurchases Will Support Future Margins And Upside Potential
Fair Value: US$175 15.0% undervalued intrinsic discount
5 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Nutex Health Inc. Key Details
Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
Aug 06, 2026
- 14.01
- 50.58%
- 10.95%
- 9.3%
About NUTX
- Founded
- 2011
- Employees
- 1005
- CEO
- WebsiteView website
Nutex Health Inc. operates as a healthcare services and operations company in the United States. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The Hospital segment develops and operates a network of micro hospitals, specialty hospitals, and hospital outpatient departments that offer healthcare services, including emergency room care, inpatient care, and behavioural health. It also provides imaging services, such as CT scan, X-ray, MRI, ultrasound, etc.; laboratory services; and onsite inpatient pharmacies. The PHM segment provides management, administrative, and other support services to its affiliated hospitals and physician groups by establishing and operating provider networks, such as independent physician associations (IPAs); and a cloud-based technology platform for IPAs. The Real Estate segment owns and leases land and hospital buildings. Nutex Health Inc. was founded in 2011 and is headquartered in Houston, Texas.
